Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

221
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
221
What is Genetic Engineering?00:49

What is Genetic Engineering?

74.9K
Overview
74.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PPMO therapy for dysferlinopathy induces pseudoexon skipping and restoration of functional protein.

JCI insightĀ·2026
Same author

Intravenous administration of an engineered AAV9-gene-silencing vector suppresses human SOD1 and extends survival in an ALS mouse model.

Nature communicationsĀ·2026
Same author

A next-generation HDAC6 inhibitor for amyotrophic lateral sclerosis and frontotemporal dementia.

Brain : a journal of neurologyĀ·2025
Same author

Dynamic changes in chromosome and nuclear architecture during maturation of normal and ALS C9orf72 motor neurons.

bioRxiv : the preprint server for biologyĀ·2025
Same author

Ultrasound detection of lymphatic bubbles in a porcine dive model.

Journal of applied physiology (Bethesda, Md. : 1985)Ā·2025
Same author

Paramagnetic rim lesions are highly specific for multiple sclerosis in real-world data.

Brain communicationsĀ·2025

Related Experiment Video

Updated: Aug 29, 2025

Intramuscular Injections Along the Motor End Plates: A Minimally Invasive Approach to Shuttle Tracers Directly into Motor Neurons
10:57

Intramuscular Injections Along the Motor End Plates: A Minimally Invasive Approach to Shuttle Tracers Directly into Motor Neurons

Published on: July 13, 2015

12.8K

Approaches to Gene Modulation Therapy for ALS.

Katharina E Meijboom1, Robert H Brown2

  • 1Department of Neurology, University of Massachusetts Medical School, Worcester, MA, 01605, USA.

Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|September 6, 2022
PubMed
Summary

Gene modulation therapies offer new hope for amyotrophic lateral sclerosis (ALS) treatment by targeting key genes. Advances in gene silencing, correction, and augmentation are paving the way for future clinical trials and improved patient outcomes.

Keywords:
Adeno-associated virus (AAV)Amyotrophic lateral sclerosis (ALS)Antisense oligonucleotides (ASOs)CRISPR/Cas9Gene therapyMicroRNA

More Related Videos

Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis
08:59

Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis

Published on: July 16, 2021

2.7K
ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
15:48

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies

Published on: July 29, 2007

9.7K

Related Experiment Videos

Last Updated: Aug 29, 2025

Intramuscular Injections Along the Motor End Plates: A Minimally Invasive Approach to Shuttle Tracers Directly into Motor Neurons
10:57

Intramuscular Injections Along the Motor End Plates: A Minimally Invasive Approach to Shuttle Tracers Directly into Motor Neurons

Published on: July 13, 2015

12.8K
Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis
08:59

Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis

Published on: July 16, 2021

2.7K
ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
15:48

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies

Published on: July 29, 2007

9.7K

Area of Science:

  • Neuroscience
  • Genetics
  • Biotechnology

Background:

  • Amyotrophic lateral sclerosis (ALS) is a progressive motor neuron disease with limited therapeutic options.
  • Understanding ALS genetics and disease mechanisms is crucial for developing effective treatments.

Purpose of the Study:

  • To review recent clinical and preclinical advances in gene modulation therapies for ALS.
  • To highlight the potential of gene silencing, correction, and augmentation strategies for ALS treatment.

Main Methods:

  • Review of clinical trials and preclinical studies involving gene modulation for ALS.
  • Focus on adeno-associated virus (AAV)-mediated microRNAs and antisense oligonucleotides (ASOs).
  • Targeting common ALS genes such as SOD1, C9ORF72, FUS, and ATXN2.

Main Results:

  • Six gene modulation therapies have been tested in ALS patients.
  • These therapies target the gain-of-function pathology of specific ALS-associated genes.
  • Gene modulation approaches show promise in preclinical and early clinical settings.

Conclusions:

  • Gene modulation strategies represent a promising frontier for ALS therapy development.
  • These approaches have the potential to significantly impact future research and clinical practice for ALS.
  • Innovations in gene therapy could transform treatment outcomes for this devastating disease.